type_of_cancer: rms
cancer_study_identifier: rms_msk_2023
name: Extremity Rhabdomyosarcomas (MSK, NPJ Precision Oncology 2023)
description: Targeted sequencing of 24 rhabdomyosarcoma tumors and their matched normals via MSK-IMPACT.